Total submissions: 23
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172761 | SCV000051566 | benign | Hypertrophic cardiomyopathy | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000035662 | SCV000059313 | benign | not specified | 2008-01-18 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000035662 | SCV000110304 | benign | not specified | 2013-03-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000035662 | SCV000170451 | benign | not specified | 2011-07-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000035662 | SCV000303200 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000252619 | SCV000317846 | benign | Cardiovascular phenotype | 2015-03-11 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV000604115 | SCV000372393 | likely benign | Hypertrophic cardiomyopathy 4 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000289076 | SCV000372394 | likely benign | Left ventricular noncompaction 10 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Genome Diagnostics Laboratory, |
RCV000604115 | SCV000743573 | benign | Hypertrophic cardiomyopathy 4 | 2014-10-09 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000604115 | SCV000744869 | benign | Hypertrophic cardiomyopathy 4 | 2015-09-21 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000757503 | SCV000885756 | benign | not provided | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000776002 | SCV000910535 | benign | Cardiomyopathy | 2018-03-19 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000757503 | SCV000987330 | benign | not provided | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000172761 | SCV001000287 | benign | Hypertrophic cardiomyopathy | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000289076 | SCV002014346 | benign | Left ventricular noncompaction 10 | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000604115 | SCV002014347 | benign | Hypertrophic cardiomyopathy 4 | 2021-09-05 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000172761 | SCV004834732 | benign | Hypertrophic cardiomyopathy | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000757503 | SCV005224335 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000604115 | SCV000733063 | benign | Hypertrophic cardiomyopathy 4 | no assertion criteria provided | clinical testing | ||
Stanford Center for Inherited Cardiovascular Disease, |
RCV000757503 | SCV000924847 | benign | not provided | 2017-10-03 | no assertion criteria provided | provider interpretation | |
Clinical Genetics, |
RCV000035662 | SCV001920515 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000035662 | SCV001952814 | benign | not specified | no assertion criteria provided | clinical testing | ||
Cohesion Phenomics | RCV000172761 | SCV003800609 | benign | Hypertrophic cardiomyopathy | 2022-10-10 | no assertion criteria provided | clinical testing |